Do Subsidiary Treatments Increase Threat Of Dying for Cancer Clients?

Do Subsidiary Treatments Increase Threat Of Dying for Cancer Clients?

This post is the main 2018 NMJ Oncology Unique Issue. Grab the concern here.

Research

Johnson SB, Playground HS, Gross CP, Yu JB. Subservient treatments, refusal of main-stream disease therapies, and survival among customers with curable types of cancer. JAMA Oncol. 2018;4(10):1375-1381.

Build

A retrospective observational analysis of data obtained from the state Cancer Database (NCDB)